Rosenberg Noah L.
CMO
Rosenberg Noah L. has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Aug 18, 2026.
On the most recent filing, Rosenberg Noah L. is listed as CMO at Verrica Pharmaceuticals Inc. Inside the rolling window, Rosenberg Noah L. reported 3 open-market purchases totaling $41K in VRCA and no open-market sales. The largest disclosed transaction in the window is a purchase of 4,200 VRCA shares on Aug 17, 2026, worth $21K.
Companies traded
Other insiders at VRCA
Insider Buying
$41K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Rosenberg Noah L. made?
Rosenberg Noah L. has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Rosenberg Noah L. trade?
Rosenberg Noah L. has filed SEC Form 4 disclosures for 1 company, including VRCA.
When was Rosenberg Noah L.'s most recent SEC Form 4 filing?
Rosenberg Noah L.'s most recent SEC Form 4 filing on Tracefour is dated Aug 18, 2026.
What is Rosenberg Noah L.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Rosenberg Noah L. is listed as CMO.
What is Rosenberg Noah L.'s total buy and sell value in the current window?
Inside the rolling retention window, Rosenberg Noah L. bought $41K and sold $0 based on SEC Form 4 filings.
What was Rosenberg Noah L.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 4,200 VRCA shares on 2026-08-17, worth $21K, per SEC Form 4 filings.